Form 8-K - Current report:
SEC Accession No. 0001104659-20-027472
Filing Date
2020-03-02
Accepted
2020-03-02 07:07:37
Documents
16
Period of Report
2020-03-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2011253d2_8k.htm   iXBRL 8-K 46560
2 EXHIBIT 2.1 tm2011253d2_ex2-1.htm EX-2.1 491980
3 EXHIBIT 99.1 tm2011253d2_ex99-1.htm EX-99.1 33546
7 GRAPHIC tm2011253d2_ex99-1img01.jpg GRAPHIC 13421
8 GRAPHIC tm2011253d2_ex99-1img02.jpg GRAPHIC 17283
  Complete submission text file 0001104659-20-027472.txt   918709

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA gild-20200301.xsd EX-101.SCH 3180
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gild-20200301_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gild-20200301_pre.xml EX-101.PRE 22706
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2011253d2_8k_htm.xml XML 3498
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19731 | Film No.: 20674188
SIC: 2836 Biological Products, (No Diagnostic Substances)